SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-132538
Filing Date
2020-12-04
Accepted
2020-12-04 18:00:39
Documents
1
Period of Report
2020-11-17

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 5393
  Complete submission text file 0001104659-20-132538.txt   6730
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Issuer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address HENRIKSHOJ 8 ROOM 4 VEDBAEK G7 DK-2950
Business Address
Rajah Vignesh (Reporting) CIK: 0001815042 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38650 | Film No.: 201370893